AB

Avego Bioscience Capital

North America, Georgia, United States, Alpharetta

Description

Avego Bioscience Capital is an investment firm.

Investor Profile

Avego Bioscience Capital has backed more than 6 startups, with 3 new investments in the last 12 months alone. The firm has led 0 rounds, about 0% of its total and boasts 1 exits across its portfolio.

Investment Focus Highlights

  • Concentrates on Series C, Series B, Series D rounds (top funding stages).
  • Majority of deals are located in United States, Switzerland.
  • Strong thematic focus on Biotechnology, Therapeutics, Health Care.

Stage Focus

  • Series C (50%)
  • Series B (33%)
  • Series D (17%)

Country Focus

  • United States (83%)
  • Switzerland (17%)

Industry Focus

  • Biotechnology
  • Therapeutics
  • Health Care
  • Biopharma
  • Medical Device
  • Oncology
  • Life Science
  • Manufacturing
  • Pharmaceutical
  • Bioinformatics
circle-line
FAQ

Frequently Asked Questions

Learn who this investor regularly partners with—both firms and angels—and explore their latest activity.

Who does Avego Bioscience Capital frequently co-invest with?

Johnson & Johnson Innovation – JJDC
North America, Massachusetts, United States, Cambridge
Co-Investments: 2
Bristol-Myers Squibb
North America, New York, United States, New York
Co-Investments: 1
EC
North America, New York, United States, New York
Co-Investments: 1
Adage Capital Management
North America, Massachusetts, United States, Boston
Co-Investments: 2
Monashee Investment Management
North America, Massachusetts, United States, Boston
Co-Investments: 2
RA Capital Management
North America, Massachusetts, United States, Boston
Co-Investments: 3
Deerfield
North America, New York, United States, New York
Co-Investments: 1
Delos Capital
Asia, Hong Kong Island, Hong Kong, Central
Co-Investments: 2
LV
North America, New York, United States, New York
Co-Investments: 2
AbbVie Biotech Ventures
North America, Illinois, United States, North Chicago
Co-Investments: 2

Which angels does Avego Bioscience Capital often collaborate with?

JR
North America, California, United States, San Francisco
Shared Deals: 1

What are some of recent deals done by Avego Bioscience Capital?

TRex Bio

South San Francisco, California, United States

TRex Bio is a biotechnology company that treats diseases like cancer, fibrotic by studying human tissues.

BioinformaticsBiopharmaBiotechnology
Series UnknownJan 27, 2026
Amount Raised: $50,000,000
EpiBiologics

San Mateo, California, United States

EpiBiologics develops antibody-based targeted therapies against membrane and extracellular proteins.

BiotechnologyHealth CareMedicalTherapeutics
Series BJan 8, 2026
Amount Raised: $107,000,000
MapLight Therapeutics

Palo Alto, California, United States

MapLight Therapeutics is a biopharma company that offers a platform designed to discover and develop therapeutics for brain disorders.

BiopharmaBiotechnologyLife ScienceMedical
Series DJul 28, 2025
Amount Raised: $372,500,000
TRex Bio

South San Francisco, California, United States

TRex Bio is a biotechnology company that treats diseases like cancer, fibrotic by studying human tissues.

BioinformaticsBiopharmaBiotechnology
Series BNov 13, 2024
Amount Raised: $84,000,000
Alentis Therapeutics

Allschwil, Basel-Landschaft, Switzerland

ALENTIS Therapeutics is a Swiss-French biotech company developing novel therapeutics in advanced liver disease and cancer.

BiotechnologyManufacturingPharmaceuticalTherapeutics
Series DNov 12, 2024
Amount Raised: $181,400,000
Evommune

Palo Alto, California, United States

Evommune is a biotechnology company that develops therapeutics that halt progressive disease and address their symptoms.

BiotechnologyHealth CareLife Science
Series COct 31, 2024
Amount Raised: $115,000,000
Antios Therapeutics

Atlanta, Georgia, United States

Antios Therapeutics is a biopharmaceutical company developing innovative therapies for viral diseases.

BiopharmaBiotechnologyTherapeutics
Series BNov 3, 2021
Amount Raised: $75,000,000
Ribon Therapeutics

Cambridge, Massachusetts, United States

Ribon Therapeutics is a biotechnology company focused on the development of therapeutics treatments targeting stress support pathways.

BiotechnologyHealth CareMedical DeviceTherapeutics
Series CJun 14, 2021
Amount Raised: $65,000,000
Caribou Biosciences

Berkeley, California, United States

Caribou Biosciences is a biotechnology company that develops CRISPR technologies and allogenic cell therapies for oncology.

BiotechnologyHealth CareOncologyTherapeutics
Series CMar 3, 2021
Amount Raised: $115,000,000

Find More Investors Like Avego Bioscience Capital

Discover similar investors in our database and build your perfect investor list.

Need help with your fundraising strategy?Read our fundraising guides

Avego Bioscience Capital | Pipeseed